Unicycive Therapeutics Inc
UNCY
Market Cap$35.26M
Close$
$0.04
99.4% downside
Current Fair Value
99.4% downsideOvervalued by 99.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $35.26 Million |
|---|---|
| Enterprise Value | $17.44 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.24 |
| Beta | 2.35 |
| Outstanding Shares | 37,914,812 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.48 |
|---|---|
| PEG | 0.47 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.4 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Insider Trades
ESG Score
No data